Gland Pharma Limited's Board of Directors has approved the reappointment of Ms. Naina Lal Kidwai as an Independent Director for a second consecutive term. The decision was announced following a board meeting held on April 09, 2026, marking a significant governance development for the pharmaceutical company.

Board Meeting Outcome

The board meeting resulted in the approval of Ms. Kidwai's reappointment for a second term of five consecutive years. The appointment details are structured as follows:

Regulatory Compliance

The reappointment decision was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has committed to obtaining shareholder approval as required under Regulation 25(2A) of the Listing Regulations within stipulated timelines through postal ballot and e-voting procedures. The formal communication was sent to both BSE Limited and National Stock Exchange of India Limited on the same day.

Director Profile and Qualifications

Ms. Naina Lal Kidwai brings extensive experience to the board, currently serving as Chairman of Rothschild & Co India. Her professional portfolio includes:

• Senior Advisor for Advent Private Equity
• Senior Advisor for TPG Rise Climate
• Venture Advisor for Lightspeed Venture Partners, India
• Non-Executive Director on boards of Holcim, UPL, and Biocon
• Past President of FICCI (Federation of Indian Chambers of Commerce & Industry)

Academic and Professional Background

Ms. Kidwai holds an MBA from Harvard Business School and is a recipient of the Padma Shri for her contribution to Trade and Industry. She previously served as Executive Director on the Board of HSBC Asia Pacific and Chairman of HSBC India until December 2015, and was on the global Board of Nestle until April 2018. She has authored three books including bestsellers "30 women in Power: Their Voices, Their Stories" and "Survive Or Sink: An Action Agenda for Sanitation, Water, Pollution, and Green Finance".

Current Engagements and Contributions

Beyond her corporate roles, Ms. Kidwai is actively engaged in various advisory and leadership positions. She serves as Chair of FICCI's Water Mission and Sustainability Council, and is the Founder and Chair of the India Sanitation Coalition. Her expertise spans environmental sustainability, water management, and women's empowerment initiatives. She is also a member of the INDO-ASEAN Business Council, Army Group Insurance Fund's investment advisory committee, Harvard Business School's South Asia Advisory Board and Standard Chartered Bank's International Advisory Council.

The reappointment reflects Gland Pharma's commitment to maintaining experienced leadership in its governance structure, leveraging Ms. Kidwai's extensive background in finance, sustainability, and corporate governance for continued strategic guidance.

Gland Pharma Limited has strengthened its senior management team with the appointment of Mr. Prasadha Rao Lysetti as Senior Vice-President (Head - Operations), effective April 06, 2026. The pharmaceutical company announced this key leadership addition in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Appointment Details

The appointment represents a strategic addition to Gland Pharma's operations leadership, with Mr. Lysetti assuming the role of Senior Management Personnel within the organization.

Professional Background and Expertise

Mr. Prasadha Rao Lysetti brings extensive pharmaceutical industry experience to his new role at Gland Pharma. His professional profile demonstrates significant expertise in pharmaceutical manufacturing and operations management.

Experience and Specialization

• Industry Experience: 25+ years of progressive expertise
• Core Competencies: Managing complex formulations and large-scale pharmaceutical manufacturing
• Operational Focus: Quality-centric operations and operational efficiency enhancement
• Leadership Areas: Lean and operational excellence initiatives
• Global Exposure: Experience across diverse cultures and global locations

Career History

Prior to joining Gland Pharma, Mr. Lysetti held positions at several prominent pharmaceutical organizations:

• Cronus Pharma India Private Limited (Rising Pharmaceuticals Group)
• Vitema Pharmaceuticals
• Eugia Pharma Specialities Limited
• Dr. Reddy's Laboratories Limited
• Glenmark Generics Ltd
• Pharma Care FZE LLC

Educational Qualifications and Certifications

Mr. Lysetti's educational background reflects his commitment to continuous learning and professional development:

Strategic Significance

The appointment of Mr. Lysetti as Senior Vice-President (Head - Operations) aligns with Gland Pharma's focus on operational excellence and manufacturing efficiency. His extensive experience in pharmaceutical operations and proven track record in quality management and operational improvements position him to contribute significantly to the company's operational objectives.

The company has fulfilled all disclosure requirements under SEBI regulations, providing comprehensive details about the appointment in accordance with regulatory guidelines.